Cargando…
When CAR Meets Stem Cells
The generation of immune cells from human pluripotent stem cells (embryonic stem cells and induced pluripotent stem cells) has been of keen interest to regenerative medicine. Pluripotent stem cell-derived immune cells such as natural killer cells, macrophages, and lymphoid cells, especially T cells,...
Autor principal: | Lee, Jung Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514932/ https://www.ncbi.nlm.nih.gov/pubmed/31013813 http://dx.doi.org/10.3390/ijms20081825 |
Ejemplares similares
-
When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies
por: Dai, Xiaofeng, et al.
Publicado: (2022) -
When Long Noncoding RNAs Meet Genome Editing in Pluripotent Stem Cells
por: Chen, Fuquan, et al.
Publicado: (2017) -
When stem cells meet COVID-19: recent advances, challenges and future perspectives
por: Li, Shasha, et al.
Publicado: (2022) -
CAR‐T therapy: Prospects in targeting cancer stem cells
por: Cui, Xiaoyue, et al.
Publicado: (2021) -
Turn to TCRs when CARs fail
por: Stauss, Hans J.
Publicado: (2017)